CHEBI:66336 - xenovulene A

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name xenovulene A
ChEBI ID CHEBI:66336
Definition A sesquiterpenoid based on a humulene skeleton. It is isolated from Sarocladium strictum and has been shown to exhibit inhibitory activity against GABA receptor.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C22H30O4
Net Charge 0
Average Mass 358.47120
Monoisotopic Mass 358.21441
InChI InChI=1S/C22H30O4/c1-13-6-7-15-19-16-14(12-25-19)17(23)18(24)20(16)26-22(15,4)10-5-9-21(2,3)11-8-13/h5,8-9,14-16,19,24H,6-7,10-12H2,1-4H3/b9-5+,13-8+/t14-,15-,16-,19-,22+/m0/s1
InChIKey WDFUVZRTUNQXHC-KVPIFFDFSA-N
SMILES [H][C@@]12CO[C@@]3([H])[C@]4([H])CC\C(C)=C\CC(C)(C)\C=C\C[C@@]4(C)OC(=C(O)C1=O)[C@@]23[H]
Metabolite of Species Details
Sarocladium strictum (NCBI:txid5046) See: PubMed
Roles Classification
Biological Role(s): metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
GABA antagonist
A compound that inhibits the action of gamma-aminobutyric acid.
Application(s): GABA antagonist
A compound that inhibits the action of gamma-aminobutyric acid.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing xenovulene A (CHEBI:66336) has role GABA antagonist (CHEBI:65259)
xenovulene A (CHEBI:66336) has role metabolite (CHEBI:25212)
xenovulene A (CHEBI:66336) is a cyclic ether (CHEBI:37407)
xenovulene A (CHEBI:66336) is a enone (CHEBI:51689)
xenovulene A (CHEBI:66336) is a organic heterotetracyclic compound (CHEBI:38163)
xenovulene A (CHEBI:66336) is a sesquiterpenoid (CHEBI:26658)
IUPAC Name
(2aR,5aR,11E,14aS,14bS,14cS)-4-hydroxy-5a,9,9,12-tetramethyl-2a,5a,6,9,10,13,14,14a,14b,14c-decahydro-1,5-dioxacyclopenta[cd]cycloundeca[f]inden-3(2)-one
Registry Number Type Source
7310576 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
7649852 PubMed citation Europe PMC
9262310 PubMed citation Europe PMC
Last Modified
15 July 2013